Oruka Therapeutics (ORKA) Enterprise Value (2010 - 2026)
Oruka Therapeutics' quarterly Enterprise Value came in at -$384.7 million in Q1 2026, up 39.35% year-on-year from -$276.1 million in Q1 2025, and up 49.87% quarter-over-quarter from -$767.5 million in Q4 2025.
Oruka Therapeutics has reported Enterprise Value for 17 years, with the latest figure at -$384.7 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 39.35% year-over-year to -$384.7 million; the trailing twelve-month figure through Mar 2026 stood at -$384.7 million (up 39.35% YoY), and the FY2025 full-year result was -$767.5 million, down 104.32% from the prior year.
- Enterprise Value for Q1 2026 stood at -$384.7 million, up from -$767.5 million in the prior quarter.
- The five-year high for Enterprise Value was -$33.3 million in Q2 2024, with the low at -$767.5 million in Q4 2025.
- Average Enterprise Value over 5 years is -$214.6 million, with a median of -$46.4 million recorded in 2022.
- Year-over-year, Enterprise Value sank 1666.86% in 2025 and soared 39.35% in 2026.
- Tracing ORKA's Enterprise Value over 5 years: stood at -$42.4 million in 2022, then grew by 11.81% to -$37.4 million in 2023, then slumped by 903.57% to -$375.6 million in 2024, then slumped by 104.32% to -$767.5 million in 2025, then soared by 49.87% to -$384.7 million in 2026.
- The last three Enterprise Value figures came in at -$384.7 million (Q1 2026), -$767.5 million (Q4 2025), and -$346.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | -384.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -384.72 Mn |
| Dec 31, 2025 | -767.51 Mn |
| Sep 30, 2025 | -346.90 Mn |
| Jun 30, 2025 | -328.41 Mn |
| Mar 31, 2025 | -634.36 Mn |
| Dec 31, 2024 | -375.65 Mn |
| Sep 30, 2024 | -403.32 Mn |
| Jun 30, 2024 | -33.28 Mn |
| Mar 31, 2024 | -35.90 Mn |
| Dec 31, 2023 | -37.43 Mn |
| Sep 30, 2023 | -38.49 Mn |
| Jun 30, 2023 | -40.16 Mn |
| Mar 31, 2023 | -40.85 Mn |
| Dec 31, 2022 | -42.45 Mn |
| Sep 30, 2022 | -43.94 Mn |
| Jun 30, 2022 | -46.44 Mn |
| Mar 31, 2022 | -49.06 Mn |
| Dec 31, 2021 | -53.36 Mn |
| Sep 30, 2021 | -58.31 Mn |
| Jun 30, 2021 | -63.20 Mn |
| Mar 31, 2021 | -66.93 Mn |
| Dec 31, 2020 | -49.07 Mn |
| Sep 30, 2020 | -51.10 Mn |
| Jun 30, 2020 | -11.04 Mn |
| Mar 31, 2020 | -6.67 Mn |
| Dec 31, 2019 | -8.36 Mn |
| Sep 30, 2019 | -9.65 Mn |
| Jun 30, 2019 | -9.97 Mn |
| Mar 31, 2019 | -8.01 Mn |
| Dec 31, 2018 | -6.61 Mn |
| Sep 30, 2018 | -8.08 Mn |
| Jun 30, 2018 | -9.64 Mn |
| Mar 31, 2018 | -12.10 Mn |
| Dec 31, 2017 | -11.75 Mn |
| Sep 30, 2017 | -15.95 Mn |
| Jun 30, 2017 | -16.01 Mn |
| Mar 31, 2017 | -19.21 Mn |
| Dec 31, 2016 | -21.16 Mn |
| Sep 30, 2016 | -23.47 Mn |
| Jun 30, 2016 | -26.36 Mn |
| Mar 31, 2016 | -30.63 Mn |
| Dec 31, 2015 | -38.80 Mn |
| Sep 30, 2015 | -41.48 Mn |
| Jun 30, 2015 | -44.09 Mn |
| Mar 31, 2015 | -12.18 Mn |
| Dec 31, 2014 | -15.35 Mn |
| Sep 30, 2014 | -17.25 Mn |
| Jun 30, 2014 | -19.38 Mn |
| Mar 31, 2014 | -21.20 Mn |
| Dec 31, 2013 | -16.76 Mn |
| Sep 30, 2013 | -18.63 Mn |
| Jun 30, 2013 | -20.37 Mn |
| Mar 31, 2013 | -3.54 Mn |
| Dec 31, 2012 | -2.92 Mn |
| Sep 30, 2012 | -3.08 Mn |
| Jun 30, 2012 | -3.18 Mn |
| Mar 31, 2012 | -4.23 Mn |
| Dec 31, 2011 | -5.94 Mn |
| Sep 30, 2011 | -5.75 Mn |
| Jun 30, 2011 | -7.46 Mn |
| Mar 31, 2011 | -5.09 Mn |
| Dec 31, 2010 | -7.03 Mn |
| Sep 30, 2010 | -7.91 Mn |
| Jun 30, 2010 | -9.92 Mn |